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Abstract
Introduction: Psoriasis is a chronic skin disease charac-
terized by scaly patches affecting approximately 2-5% 
of the population. The disease has a negative impact 
on quality of life and, therefore, psoriatic patients often 
develop depression. Our work deals with quality of life 
and depression in psoriasis sufferrers and strives to de-
termine the correlation between their quality of life and 
depression.
Methods: The research took place in the University 
Hospital Olomouc in 2017 and used questionnaires 
WHOQOL-BREF and BDI-II. 50 patients with psoriasis 
were chosen randomly. To process the data we used 
Mann-Whitney test (the level of significance = 5%) and 
Spearman´s correlation coefficient (the level of signifi-
cance = 1%).
Results: The results proved that psoriasis has a signifi-
cant impact on quality of life. The scores for the ove-
rall life quality as well as for individual domains were 
significantly lower in psoriatic patients than in the 
control group (p<0.001). The degree of depression in 
patients with psoriasis showed statistically significant 
correlation in all domains of the quality of life. We pro-
ved negative correlation in the overall quality of life (rs 
=– 0.691**), physical condition (rs =-0.499
**), social rela-
tions (rs =-0.546




Conclusion: With regard to the ascertained negative cor-
relation between psoriasis and depression and lower 
quality of life of the sufferers compared to the healthy 
population, it is essential for healthcare professionals 
to pay attention not only to somatic manifestations of 
the disease but also to the patients´ mental health.





Corresponding author:  
Jiří Vévoda  
E-mail: jiri.vevoda@upol.cz
Psoriasis – the Impact on an 
Individual’s Mental State  
and Quality Of Life
J. appl. health sci. 2019; 5(2): 187-195
188 Vévodová Š. et al. Psoriasis – the Impact on an Individual’s Mental State and Quality Of Life. J. appl. health sci. 2019; 5(2): 179-187
The negative factor accompanying psoriasis is stigma-
tization (1,14,15). Due to their aesthetic aspect skin dis-
eases may be one of the main reasons for social rejec-
tion, which negatively affects personal and social life of 
sufferers (14). Psoriasis is the disease that significantly 
affects the way patients perceive themselves and the 
way they are perceived by others (1). Social rejection 
results in their sadness and bad mood (16). Due to vis-
ible manifestation of psoriasis the sufferers avoid swim-
ming pools and hairdresser´s or even public transport 
(15). 
Psoriasis is also associated with higher incidence of 
obesity, smoking and alcohol abuse. This results in 
negatively affected quality of life and higher incidence 
of depression (17). Partnership and sexual problems 
represent another component part of quality of life 
(18). Patients with severe psoriasis are rather skeptical 
about finding a life partner (19). 
Depression in patients with psoriasis
Everyday bad mood contributes to worsened symp-
toms of psoriasis and to poor quality of life as well as 
development of depression (20). Compulsive itching 
related to psoriasis affects the mental state of patients 
and depression incidence (2,21). The incidence of de-
pression in patients with psoriasis is rather variable and 
the prevalence is between 10-62% (11,25,22). In psori-
atic patients depression develops 4-5 times more fre-
quently than in healthy people, and the risk increases 
with severity of the disease (9,23). Stigmatization, and 
isolation from healthy people, also contributes to de-
pression (15). Suicidal ideation was found in almost 
20% psoriasis sufferrers (1,22). In the Netherlands as 
many as 50% of patients with psoriasis were referred by 
their dermatologists to psychological counselling and 
psychiatric treatment . However, only 8% out of them 
did undergo the recommended therapy. The other 50% 
of patients were not informed about the therapy by 
their attending physicians (24). 17.8% of these patients 
are on antidepressants (25). The negative impact of 
psoriasis on a patient´s psyche is often more significant 
indicator of disability than the skin disease itself (26). 
Depression and quality of life
One of the main consequences of depression is its nega-
tive impact on a patient´s quality of life. Depression sig-
nificantly worsens functions of an individual in such life 
areas as health condition or performance of social roles 
(27). Depression may even restrict functions in all do-
Introduction
Psoriasis is a chronic skin disease characterized by 
scaly patches found anywhere on the body. It is an 
auto-immune genetically mediated inflammatory skin 
disease affecting approximately 2-5% of the world pop-
ulation. Men and women are affected equally (1,2,3). In 
individual parts of the world the prevalence is different, 
a higher prevalence is found in developed countries 
(4.6% of the population), e.g. in the USA psoriasis is the 
most frequent auto-immune disease with the preva-
lence of 0.9% (4). The disease may develop in any age, 
however, the onset is most frequent in people under 40 
(3). The disease significantly affects everyday life of the 
patients and restricts them in many areas of their life. 
The problems are usually associated with physical ap-
pearance which leads to stigmatization. This affects the 
patient´s psyche and may result in depression (5). Psy-
chological problems associated with the disease affect 
a sufferer´s quality of life more substantially than the 
skin disease and its manifestations (6). 
Quality of life of psoriasis sufferers
Quality of life is a multidimensional concept that is diffi-
cult to precisely define due to its complexity. It involves 
both objective and subjective evaluation of different ar-
eas of life related especially to health and mental state 
as well as social interactions (7). Healthcare profession-
als usually focus on the visible manifestations of the 
disease. However, a complex approach resulting in the 
better quality of sufferers´ life is necessary (8). 
Due to frequent manifestations in the visible places 
psoriasis brings about a number of problems, such as 
low self-esteem, sexual dysfunction, anxiety and de-
pression. Poor or very poor quality of life was found in 
16.6% of patients with psoriasis (9). Dubertret et al. (12) 
carried out a European survey among 17 900 patients 
with psoriasis: 77% of respondents considered psoriasis 
a fundamental life problem, 48% of respondents stated 
that the quality of their life is affected especially by a 
worsened physical appearance. The degree of quality of 
life reduction is also given by severity of the disease (2). 
In the patients who are aware of which aspects of life 
are the most important for them the quality of life is 
better, they can cope with the disease to some extent 
(13). 
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shortened version was used to minimize time demands 
and burden put on the respondents (31).
WHOQOL–BREF includes 26 questions in which re-
spondents subjectively assess quality of their life in the 
last two weeks. There are 24 items representing the 
sample of the best psychometric characteristics from 
WHOQOL–100 questionnaire that are subdivided into 
four domains: physical health, experiencing, social re-
lations and environment, and two separated items as-
sessing the overall quality of life and health condition. 
Mean gross scores of individual domains are calculat-
ed. The mean gross score for the first domain assess-
ing physical health is based on seven questions: q3, q4, 
q10, q15, q16, q17, q18. The domain of experiencing is 
based on six questions: q5, q6, q7, q11, q19, q26. So-
cial relations are specified by three questions: q20, q21 
and q22. Environment is assesssed by eight items: q8, 
q9, q12, q13, q14, q23, q24 and q25. The questions on 
the overall quality of life q1 and health condition q2 are 
expressed separately by the mean score based on the 
five-point Likert scale 1-5, and the higher the number 
the better quality of life.
BD–II questionnaire is the latest version of Beck Self-
Rating Depression Scale from 1996 and it is used to 
detect symptoms of depression and their severity. The 
tool includes 21 items focused on affective, cognitive, 
motivational and physiological symptoms of depres-
sion. Respondents are asked to choose one of the four 
offered answers that is most consistent with their psy-
chological condition over the last 30 days. The answers 
are scored on a 4-point scale from 0 to 3 points. The de-
gree of depression is determined by the points added 
where the maximum sum total is 63.
The test results are given with the help of the following 
cut off scores:
 ▶ 0-13 points – subtreshold depression
 ▶ 14-19 points – mild depression
 ▶ 20-28 points – moderate depression
 ▶ 29-63 points – severe depression (32).
Organization of research of the basic set
Our study is cross-sectional. The survey was carried out 
in the University Hospital Olomouc, the outpatient de-
partment of the Clinic of Dermatology and Venereology. 
The department works with the highest number of pso-
riasis sufferers in the Olomouc Region. Only outpatients 
took part in the survey. The data were collected with 
the method of simple intentional selection. The ques-
mains of life quality (28). Depression is characterized by 
symptoms such as increased fatigue, loss of appetite, 
sadness, problems with sleeping, low energy or cogni-
tive impairment. The symptoms significantly affect the 
patient´s life. Ability to perform everyday routines is 
significantly impaired as well as abilities to fulfill fam-
ily and work roles of the patient. Depression also leads 
to suicidal thoughts and behaviour (29). It has been 
proved that quality of life is significantly influenced by 
psychological aspects. Therefore, depression and other 
mental disorders should not be underestimated – on 
the contrary, they are significant predictors affecting 
quality of life (28). Poor quality of life, stigmatization 
and dissatisfaction with the treatment of psoriasis of-
ten result in insufficient patient cooperation and com-
pliance, followed by inappropriate treatment proce-
dures and lower treatment efficiency. This results in a 
patient‘s compromised well-being, and thus a vicious 
circle is formed (30). When the depression symptoms 
are reduced, manifestations of psoriasis reduce as well, 
and the patients‘ quality of life improves.
Methods
Aims
The aim of our survey was to determine the quality of 
life and the degree of depression in patients with pso-
riasis, and then to compare the rate of quality of life and 
depression between the research sample and the con-
trol group. Another aim was to establish the relation-
ship between the degree of depression and the quality 
of life in patients with psoriasis.
Research methods
We chose the technique of quantitative research and 
used standardized questionnaires WHOQOL–BREF (the 
quality of life questionnaire WHO – its shortened ver-
sion) (31) and BDI–II (Beck Self-Rating Depression Scale 
) (32). The Czech version of WHOQOL–BREF is used for an 
individual´s quality of life self-rating. It is a shortened 
version of the original WHOQOL–100 questionnaire that 
was prepared by a working group of experts who used 
data analyses from twenty world research centres. The 
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Results
The patient group included 28 men and 22 women; 
the mean age = 43 (SD = 14.71, the interval from 19 to 
74 years); the mean length of disease manifestation = 
19.62 (SD = 13.66, the interval from 1 to 50 years). 11 
patients lived alone, 32 with their partners, 7 with their 
parents. 4 respondents had elementary education, 32 
completed vocational school, 21 completed secondary 
high school, 9 completed university education.
The control group included 33 men and 23 women; 
the mean age = 43.52 (SD = 14.67, the interval from 19 
to 73 years). 15 respondents lived alone, 36 with their 
partners, 5 with their parents. 3 respondents had el-
ementary education, 18 completed vocational school, 
23 completed secondary high education, 12 completed 
university studies.
The overall quality of life in the patient group was as-
sessed with the questionnaire WHOQOL-BREF. Answers 
to the question „How would you assess the quality of 
your life?“ are given in Table 1. No patient assessed the 
overall quality of their life as very poor.
To determine depression in the patients Beck Self-Rat-
ing Depression Scale for adults was used (BDI–II). The 
results are given in Table 2. Mild depression was found 
in 11 (22%), moderate in 7 (14%) and severe in 4 (8%) 
psoriasis sufferers.
Mann-Whitney test was used for statistical comparison 
of the quality of life between the research group and 
the control group (see Table 3). The comparison revea-
led that there are statistically significant differences in 
the overall quality of life as well as in individual areas of 
life. The set of psoriasis sufferers had significantly lower 
overall quality of life, health condition, physical health, 
experiencing, social relationships and environment.
Mann-Whitney test was used for statistical compari-
son of depression between the patient group and the 
control group (see Table 4). The comparison proved a 
statistically significant difference between the groups 
(p<0.001) – there was a significantly higher occurrence 
of depression in the psoriatic patients.
Spearman´s correlation coefficient was used to deter-
mine the relationship between depression and quality 
of life in patients with psoriasis. What was found was 
a significantly negative correlation between the overall 
tionnaires were distributed by the instructed nurses. 
Filled-in questionnaires were put into an enclosed en-
velope, sealed and returned into the prepared box.
Characteristics of the research set
The size of the se,t as well as the parameters monitored, 
were established according to the published studies 
(11,15). The basic parameter was the question whether 
a respondent is being treated for psoriasis. Other pa-
rameters included:
 ▶ Sex (males and females)
 ▶ Age (18 years and over)
 ▶ Marital status (living alone, with a partner, with 
parents)
 ▶ The highest education completed (elementary, 
vocational, secondary, university)
 ▶ The length of treatment (in years)
The data were collected from June 2016 till January 
2017. 60 questionnaires were distributed, 56 were re-
turned (i.e. 93.3%). 6 questionnaire sets were excluded 
due to incomplete filling in (i.e. 10%). 50 questionnaire 
sets (83.3%) were statistically processed.
Ethics
The research was approved by the Ethical Committee 
of the Faculty of Health Sciences, Palacky University, 
Olomouc.
Statistics
Data were statistically processed and analyzed with 
software IBM SPSS 19.0 and Excel (MS Office). Shapiro-
Wilk test was used to determine the normality of data 
distribution. As the distribution was not normal, the 
non-parametric Mann-Whitney test (the level of sig-
nificance = 5%) was used to determine differences be-
tween the patients and control groups. To determine 
the relationship of depression scores and quality of life 
scores the Spearman correlation coefficient (the level of 
significance = 1%) was used.
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gative correlation between the rate of depression and 
the domains of physical health (rs=-0.499
**) and social 
relationships (rs=-0.546
**), and a negative mean corre-
lation between depression and the domains of health 
condition (rs=-0.396
**) and environment (rs=-0.386
**).
quality of life established with WHOQOL-BREF questi-
onnaire and the rate of depression established with 
BDI-II (rs=-0.691
**). The outcomes suggest a significant 
negative correlation between the rate of depression 
and experiencing domain (rs=-0.600
**), a significant ne-
Table 1. Overall quality of life in psoriatic patients












Total 50 (100) 3.46 3 3 0 7 (14) 19 (38) 18 (36) 6 (12) 0,89
OQL = overall quality of life; n = number of respondents; r = arithmetic mean; Mod (x) = modus; Med (x) = median; σ = standard deviation
Table 2. Depression in psoriatic patients



















Celkem 50(100) 14.3 12.5 12 0 44 28 (56) 11 (22) 7 (14) 4 (8) 9,41
RS= research set – psoriatic patients; n = number of respondents; Mod (x) = modus; Med (x) = median; Min = minimum value; Max = 
maximum value; σ = standard deviation
Table 3. Comparison of individual domains and overall quality of life of WHOQOL-BREF 




Min Max Mod (x) Med (x) σ  p value
Overall 
quality of life
RS 50 3,46 2 5 3 3 ,885
0,000
CG 56 4,12 3 5 4 4 ,623
Physical 
health 
RS 50 24,02 13 31 26 24,50 4,148
0,000 
CG 56 29,29 21 35 28b 29,00 3,642
Experiencing
RS 50 20,74 16 28 18 20,50 3,343
0,000 
CG 56 24,88 17 29 27 25,00 2,861
Social 
relationships 
RS 50 10,82 5 15 11 11,00 2,106
0,000 
CG 56 12,34 7 15 12 12,00 1,910
Environment
RS 50 29,16 18 38 29 29,00 4,215
0,002 
CG 56 31,70 7 15 33 32,50 3,474
RS = research set – psoriatic patients; CG = control group; n = number of respondents; r = mean value; Mod (x) = modus; Med (x) = median; 
Min = minimum value; Max = maximum value; σ = standard deviation; 
Table 4. Comparison of the rate of depression between research set and control group
Depression n Mean (x) Min Max Mod (x) Med (x) σ p value
RS 50 14.3 0 44 12 12.5 9.29 0,000
CG 56 7.6 0 30 4 6 6.19 0,000
RS = research set – psoriatic patients; CG = control group; n = number of respondents; σ = standard deviation; Mod (x) = modus; Med (x) = 
median; Min = minimum value; Max = maximum value
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mental state, no illnesses, financial situation, interper-
sonal relationships, well-being, and a person’s ability 
to achieve and follow their personal interests (35). The 
results show that there is a statistically significant dif-
ference between the patients and healthy people in 
the domain of experiencing. Psoriasis sufferers have a 
poorer quality of life in this domain. We also found a 
statistically significant negative correlation between 
this domain and the rate of depression. The poorer re-
sults in the domain “Experiencing”, the higher the rate 
of depression and vice versa (rs=-0.600
**). The same 
was also found in the domain of “Physical health” and 
the rate of depression (rs=-0.499
**). Mahmutovic et al. 
(34) report a very strong negative correlation between 
“Physical health” and the rate of depression (rho=-
0.793 p = 0.0001).
We also compared the rate of depression between the 
two groups (patient vs. control). The rate of depression 
was significantly higher in psoriasis sufferers which cor-
responds to the findings of Lee et al. (11). Psoriasis is of-
ten accompanied by depression and disturbed mental 
state is usually a higher indicator of morbidity rate than 
the skin disease itself (26). The worldwide depression 
prevalence is between 15 and 20% (36). The rate of de-
pression in psoriatic patients is rather varied. Lakshma 
et al. (9) report depression in almost 79% of patients 
with psoriasis. However, some works state only 25-30% 
depression prevalence (2,26). The rate of depression in 
our research sample was established with cut off scores 
of BDI–II questionnaire. Subthreshold depression mani-
festations were found in 28 respondents (56%), mild 
depression in 11 respondents (22%), moderate depres-
sion in 7 (14%) and severe depression in 4 respondents 
(8%). Thus depression was recorded in 44% of our re-
spondents. The resulting mean score was 14.3 points. 
The same results are reported by Jankowiak et al. (15). 
Depression is the disease with a wide spectre of symp-
toms, such as fatigue, loss of appetite or sleep disor-
ders. All the symptoms reduce the ability of an individu-
al to lead a normal everyday life and may result in total 
exhaustion and failure (37). The treatment of psoriasis 
often deals with only skin problems and ignores dis-
turbed psychological state of patients (3,13). The men-
tal state of the patients should be regularly monitored 
in order to note possible mental state changes early 
and treat them appropriately (3). 
We also explored whether there exists the relationship 
between the rate of depression and quality of life in 
psoriatic patients. A strong correlation was found. This 
corresponds to the findings of similar studies that state 
Discussion
The presented work deals with the skin condition 
known as psoriasis and its potential impact on the qual-
ity of life and the rate of depression. The disease itself 
shows a significantly negative impact on the quality of 
life in almost 70% of psoriasis sufferers (10). Lakshmy et 
al. (9) used the same WHOQOL-BREF questionnaire and 
they found almost the same number of patients (35.6%) 
who stated their quality of life was neither good nor bad 
(38% in our research). However, in our study there were 
twice as much patients (14%) who considered their 
quality of life as poor or very poor (compared to 6% in 
the study by Lakshmy et al.(9)).
Another objective of our research was to establish the 
difference in the quality of life between the research 
group and the control group of respondents. The re-
sults proved significantly lower overall quality of life in 
patients with psoriasis which corresponds to the results 
given by Lee et al. (11). The resulting mean score of the 
overall quality of life in psoriasis sufferers was 3.46, i.e. 
the value below the level of the mean score of the popu-
lation norm (3.82).
Psoriasis is usually accompanied by stigmatization. 
The patients are often excluded from their social en-
vironment which results in the increased incidence of 
depression and lower quality of their life (14,15). An-
other aspect affecting the quality of life is the degree 
of satisfaction in partnership and sexual life. Problems 
occurring in an intimate relationship have a significant-
ly negative impact on this domain of the quality of life 
(15,33). In the domain “Social relationships” there is a 
statistically significant difference between the patient 
and the control group – the lower mean score in psoria-
sis sufferers shows the poorer quality of their life in the 
domain. A significantly negative correlation was found 
between this domain and the degree of depression (rs=-
0.546**) which suggests that the lower the quality of life 
the higher the rate of depression and vice versa. Mah-
mutovic et al. (34) found a similar negative correlation 
in this domain (rho=-0.598** p = 0.0001). Therefore, the 
general public should be better informed about the dis-
ease in order to reduce stigmatization and improve the 
quality of life of the patients (14,20). 
A number of authors view quality of life as a complex 
condition that must be regarded from aspects of sat-
isfaction in different domains, i.e. good physical and 
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<0,001). Stupanj depresije u bolesnika s psorijazom po-
kazao je statistički značajnu korelaciju u svim područji-
ma kvalitete života. Dokazana je negativna korelacija u 
ukupnoj kvaliteti života (rs = – 0.691 **), fizičkom stanju 
(rs = -0.499 **), društvenim odnosima (rs = -0.546 **), uku-
pnom zdravlju (rs = -0.396 **) ) i okruženju (rs = -0.386 **).
Zaključak: S obzirom na utvrđenu negativnu korela-
ciju između psorijaze i depresije i niže kvalitete života 
oboljelih u odnosu na zdravu populaciju, neophodno 
je da zdravstveni djelatnici obrate pozornost ne samo 
na somatske manifestacije bolesti, nego i na mentalno 
zdravlje pacijenata.
Ključne riječi: psorijaza, depresija, kvaliteta života, zdravstve-





1  Ústav společenských a humanitních věd, Fakulta 
zdravotnických věd, Univerzita Palackého v Olomouci, 
Česká republika
2  Fakultní nemocnice Olomouc, Česká republika
Sažetak
Uvod: Psorijaza od koje boluje otprilike 2-5% stanov-
ništva, je kronična kožna bolest koju karakteriziraju lju-
skasti plakovi. Bolest ima negativan utjecaj na kvalitetu 
života, pa stoga osobe koje boluju od psorijaze često 
razviju depresiju. Naš rad bavi se kvalitetom života i de-
presijom kod oboljelih od psorijaze te se nastoji utvrditi 
povezanost između kvalitete života i depresije.
Metode: Istraživanje je provedeno u Sveučilišnoj bolnici u 
Olomoucu 2017. godine i korišteni su upitnici WHOQOL-
BREF i BDI-II. 50 bolesnika s psorijazom odabrano je me-
todom slučajnog odabira. Za obradu podataka korišten 
je Mann-Whitneyev test (razina značajnosti = 5%) i Spe-
armanov koeficijent korelacije (razina značajnosti = 1%).
Rezultati: Rezultati su pokazali da psorijaza ima značajan 
utjecaj na kvalitetu života. Rezultati za ukupnu kvalitetu 
života kao i za pojedinačne domene bili su značajno ni-
ži u bolesnika s psorijazom nego u kontrolnoj skupini (p 
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